Senseonics (NYSE:SENS) shares took a hit today on fourth-quarter losses that missed the consensus earnings forecast. SENS shares were hit hard at market close yesterday after financial results were released, dipping -15.7% to $2.69 per share. In pre-market trading this morning, they are down -7.8% at $2.48 per share. The Germantown, Md.-based implantable continuous glucose monitor […]
Wall Street Beat
Asensus Surgical finalizes name change from TransEnterix, debuts NYSE ticker
Asensus Surgical (NYSE:ASXC) announced today that it formally completed its name and stock ticker change from TransEnterix (NYSE:TRXC). Research Park Triangle, N.C.-based Asensus announced last month that the company would change its name from TransEnterix to Asensus Surgical and introduce a new surgery category. The company aims to enter a new era of performance-guided surgery […]
Report: Permira eyeing LivaNova purchase
Private equity firm Permira has reportedly submitted a bid to acquire LivaNova (NSDQ:LIVN), which is valued at $3.7 billion. The Financial Times reported that people familiar with the situation cited an offer made in mid-February that valued London-based LivaNova’s shares at more than $80 per share. The report said talks are ongoing but there is no […]
Conformis dips 9% on Street-beating Q4 results
Conformis (NSDQ:CFMS) posted fourth-quarter results that beat the earnings consensus on Wall Street and matched on revenue. The Billerica, Mass.-based company reported losses of -$6.6 million, or -8¢ per share, on sales of $16.7 million for the three months ended Dec. 31, 2020, for a sales loss of -16.1% compared with Q4 2019. Earnings per share […]
Magenta Therapeutics rises on Street-beating Q4
Magenta Therapeutics (NSDQ:MGTA) shares ticked up today on fourth-quarter earnings that topped the consensus forecast. The Cambridge, Mass.-based stem cell transplantation technology developer posted losses of -$18.2 million, or -38¢ per share for the three months ended Dec. 31, 2020, marking a 21.8% bottom-line gain. Get the full story at our sister site, Drug Delivery Business […]
TransMedics jumps on Street-beating Q4 results
TransMedics (NSDQ:TMDX) posted fourth-quarter results this week that beat the consensus forecast on Wall Street. The Andover, Mass.-based company — a maker of transplant organ preservation tech — reported losses of -$6.3 million, or -23¢ per share, on sales of $7.6 million for the three months ended Dec. 31, 2020, for a sales growth of 25% […]
SeaSpine ticks up on 6.2% sales growth in Q4, reports losses
SeaSpine Holdings (NSDQ:SPNE) posted fourth-quarter results that missed the consensus forecast on Wall Street. The Carlsbad, Calif.-based company reported losses of $10.3 million, or -37¢ per share, on sales of $46.4 million for the three months ended Dec. 31, 2020, for a sales growth of 6.2% compared with Q4 2019. Earnings per share were -37¢, 12¢ […]
Silk Road Medical reports losses in Q4, sales up 13%
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that missed the consensus forecast on Wall Street, citing a second wave of COVID-19 in the last quarter of 2020. The Sunnyvale, Calif.-based company reported losses of -$16.8 million, or -49¢ per share, on sales of $21.1 million for the three months ended Dec. 31, 2020, for a […]
Inovio Pharmaceuticals posts Street-beating Q4, touts HPV trial results
Inovio Pharmaceuticals (NSDQ:INO) shares dipped after hours today after the company presented its fourth-quarter earnings and touted clinical trial results. INO shares finished the day up 4.5% at $11.60 per share but have since dropped -2.2% after hours to $11.35 per share. The Plymouth Meeting, Pa.-based company posted losses of -$24.3 million, or -14¢ per share, […]
Dentsply Sirona skyrockets on Street-beating Q4
Dentsply Sirona (NSDQ:XRAY) shares soared this morning on fourth-quarter results that easily topped the consensus forecast. XRAY shares were up 13.7% at $60.35 per share in mid-morning trading today. The Charlotte, N.C.-based dental solutions company posted profits of $99 million, or 45¢ per share, on sales of $1.1 billion for the three months ended Dec. 31, […]
MedTech 100 Roundup: Small slide continues
On the back of several weeks of new records and strong performances, the medtech industry has finally hit a snag in its recent ascent. MassDevice‘s MedTech 100 index ended the week (Feb. 26) at 106.65 points, marking a 1.9% dip from the 108.72-point mark set one week before (Feb. 19). This highlights a similar drop from […]
